Amitriptyline

Routes
Oral (PO)
Half-Life (t½)
PO: 21h
Formula
C20H23N
Molecular Weight
277.41 g/mol
PubChem CID
2160
Aliases
Elavil

Pharmacological Mechanism

Tertiary-amine TCA — strong serotonin + norepinephrine reuptake inhibition + H1 + muscarinic + α1 antagonism. Now used mainly off-label for chronic pain, migraine prophylaxis, neuropathic pain at low doses (10–50 mg). High anticholinergic burden in elderly.

Half-Life & Elimination Curve (PO: 21h)

100%50%25%12.5%0%0h0×t½21h1×t½42h2×t½63h3×t½3.5d4×t½4.4d5×t½0×t½ (0h): 100% remaining (~20.9 µg/L)1×t½ (21h): 50% remaining (~10.4 µg/L)2×t½ (42h): 25% remaining (~5.21 µg/L)3×t½ (63h): 12.5% remaining (~2.61 µg/L)4×t½ (3.5d): 6.3% remaining (~1.3 µg/L)5×t½ (4.4d): 3.1% remaining (~0.652 µg/L)
Plasma (PO)t½ Decay (21h)
  • 0×t½0h100% (20.9 µg/L)
  • 1×t½21h50% (10.4 µg/L)
  • 2×t½42h25% (5.21 µg/L)
  • 3×t½63h12.5% (2.61 µg/L)
  • 4×t½3.5d6.3% (1.3 µg/L)
  • 5×t½4.4d3.1% (0.652 µg/L)
Elimination t½21h (PO)
Rate Constant (ke)0.033 h⁻¹
Time to Peak (Tmax)2.6h
Est. Peak (Cmax)20.9 µg/L
Clearance (CL)36.3 L/h
97% Washout (5×t½)4.4d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References